These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
480 related articles for article (PubMed ID: 2758224)
1. The cardiovascular pharmacology of ICI 170777 ((6RS)-6-methyl-5-(pyrid-4-yl)-3H,6H-1,3,4- thiadiazin-2-one) a novel compound with positive inotropic and vasodilator effects. Collis MG; Keddie JR; Rouse W Br J Pharmacol; 1989 Jun; 97(2):409-18. PubMed ID: 2758224 [TBL] [Abstract][Full Text] [Related]
2. The cardiovascular effects of ICI 118,587: A beta 1-adrenoceptor partial agonist. Nuttall A; Snow HM Br J Pharmacol; 1982 Oct; 77(2):381-8. PubMed ID: 6128041 [TBL] [Abstract][Full Text] [Related]
3. Positive inotropy contributes to the hemodynamic mechanism of action of flosequinan (BTS 49465) in the intact dog. Greenberg S; Touhey B J Cardiovasc Pharmacol; 1990 Jun; 15(6):900-10. PubMed ID: 1694912 [TBL] [Abstract][Full Text] [Related]
4. Cardiovascular effects of (2RS,3SR)- 2-aminomethyl-2,3,7,8-tetrahydro-2,3,5,8,8-pentamethyl-6H-furo- [2,3-e]indol-7-one hydrochloride (UK-1745), a novel cardiotonic agent with vasodilatory and antiarrhythmic properties. Uchida Y; Kawada M; Sawanobori K; Sonoki H; Inoue K; Mizuno K; Itou T; Tabunoki Y; Tsukamoto M; Ohashi Y; Kyotani Y; Shimizu N; Fujii M; Nakamura M Arzneimittelforschung; 1998 Mar; 48(3):219-31. PubMed ID: 9553677 [TBL] [Abstract][Full Text] [Related]
5. Positive inotropic and hemodynamic properties of flosequinan, a new vasodilator, and a sulfone metabolite. Falotico R; Haertlein BJ; Lakas-Weiss CS; Salata JJ; Tobia AJ J Cardiovasc Pharmacol; 1989 Sep; 14(3):412-8. PubMed ID: 2476620 [TBL] [Abstract][Full Text] [Related]
6. The central and regional cardiovascular responses to intravenous and intracoronary administration of the phenyldihydropyridine elgodipine in anaesthetized pigs. Sassen LM; Soei LK; Koning MM; Verdouw PD Br J Pharmacol; 1990 Feb; 99(2):355-63. PubMed ID: 2328400 [TBL] [Abstract][Full Text] [Related]
7. In vivo pharmacological studies with SK&F 94836, a potent inotrope/vasodilator with a sustained duration of action. Gristwood RW; Comer MB; Eden RJ; Taylor EM; Turner JA; Wallduck M; Owen DA Br J Pharmacol; 1988 Apr; 93(4):893-901. PubMed ID: 3390657 [TBL] [Abstract][Full Text] [Related]
8. Cardiovascular actions of dopexamine in anaesthetized and conscious dogs. Einstein R; Abdul-Hussein N; Wong TW; Chang DH; Matthews R; Richardson DP Br J Pharmacol; 1994 Jan; 111(1):199-204. PubMed ID: 7912154 [TBL] [Abstract][Full Text] [Related]
9. Inotropic selectivity of salbutamol and terbutaline in anaesthetised, areflexic dogs. Engel B; Einstein R; Goodman AH Eur J Pharmacol; 1985 Oct; 116(1-2):97-104. PubMed ID: 4054218 [TBL] [Abstract][Full Text] [Related]
11. Changes in cardiovascular responsiveness to dopexamine and beta 1- and beta 2-adrenoceptor function after the chronic treatment of beta-adrenoceptor antagonists and agonists in anaesthetized dogs. Chang DH; Einstein R J Auton Pharmacol; 1996 Oct; 16(5):269-79. PubMed ID: 9023671 [TBL] [Abstract][Full Text] [Related]
12. Cardiostimulant and cardiodepressant effects through overexpressed human beta2-adrenoceptors in murine heart: regional differences and functional role of beta1-adrenoceptors. Heubach JF; Blaschke M; Harding SE; Ravens U; Kaumann AJ Naunyn Schmiedebergs Arch Pharmacol; 2003 Apr; 367(4):380-90. PubMed ID: 12690430 [TBL] [Abstract][Full Text] [Related]
13. The actions of a new beta-adrenoceptor blocking drug, ICI 66082, on the rabbit papillary muscle and on the dog heart. Harry JD; Knapp MF; Linden RJ Br J Pharmacol; 1974 Jun; 51(2):169-77. PubMed ID: 4155970 [TBL] [Abstract][Full Text] [Related]
14. Effect of flosequinan (BTS 49465) on myocardial oxygen consumption. Greenberg S; Touhey B; Paul J Am Heart J; 1990 Jun; 119(6):1355-66. PubMed ID: 2353621 [TBL] [Abstract][Full Text] [Related]
15. The effect of catecholamine infusions on myocardial blood flow, metabolic heat production and on general haemodynamics, before and after alprenolol (H56-28), in anaesthetized cats. Parratt JR; Wadsworth RM Br J Pharmacol; 1970 May; 38(3):554-71. PubMed ID: 4392541 [TBL] [Abstract][Full Text] [Related]
16. Urinary bladder distension: its effects on carotid baroreceptor reflex left ventricular inotropic response in the dog. Ward J; Daly MB; Wood LM J Physiol; 1995 Dec; 489 ( Pt 3)(Pt 3):857-68. PubMed ID: 8788949 [TBL] [Abstract][Full Text] [Related]
17. Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. Dose-response relationships and comparison to nitroprusside. Jaski BE; Fifer MA; Wright RF; Braunwald E; Colucci WS J Clin Invest; 1985 Feb; 75(2):643-9. PubMed ID: 3973022 [TBL] [Abstract][Full Text] [Related]
18. Cardiovascular pharmacology of 6-[4-(4'-pyridyl)aminophenyl]-4,5-dihydro-3(2H)-pyridazinone hydrochloride, a novel and potent cardiotonic agent with vasodilator properties. Narimatsu A; Kitada Y; Satoh N; Suzuki R; Okushima H Arzneimittelforschung; 1987 Apr; 37(4):398-406. PubMed ID: 3606694 [TBL] [Abstract][Full Text] [Related]
19. Influence of adenosine on the stimulatory effect of isoprenaline and insulin on myocardial contractility in vivo. Law WR; Carney PJ; McLane MP Cardiovasc Res; 1991 Feb; 25(2):151-7. PubMed ID: 1742765 [TBL] [Abstract][Full Text] [Related]
20. Characterization of adrenoceptors mediating positive inotropic responses in the ventricular myocardium of the dog. Endoh M; Shimizu T; Yanagisawa T Br J Pharmacol; 1978 Sep; 64(1):53-61. PubMed ID: 29684 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]